ZYBERNO
Stock Report
Updated Sep 1, 2026

NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)

Healthcare • NASDAQ

$2.13

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
22.0/100
POOR BUSINESS
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) scores 22/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
MARGIN OF SAFETY
Is this stock cheap or expensive relative to what the business has historically generated for owners?
-97.4%
Overvalued
Growth gap unavailable — insufficient data for reverse DCF calculation.
🎯 Expected Annual Return
-27.6%
Margin of Safety convergence — your return if the market re-prices to intrinsic value (5-yr annualised)
9.7%
Yield + growth — what the business alone earns you, even if the market never re-rates
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (-21.5%)
Debt-to-Equity (Solvency Risk):POOR (1.48x)
Operating Margin (Operational Efficiency):CRITICAL (-5.3%)
Return on Capital (Capital Efficiency):CRITICAL (-5.6%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) stock report — Zyberno Score 22/100 (POOR BUSINESS), Margin of Safety -97.4%, -28% expected annual return. Full financial analysis on Zyberno.

According to Zyberno's DCF model, NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) trades at $2.13 against an estimated intrinsic value per share of $1.08 — a -97.4% Margin of Safety based on Owner Earnings of $1.30M TTM, projected at -17.8% growth for 10 years with a 2.5% terminal growth rate. Zyberno's model translates this into a 5-year expected return of -27.6% annually.

Over the trailing twelve months, NAII generated $1.30M in Owner Earnings. Capital was deployed as follows: $5.00K returned via share buybacks, $4.34M invested in capital expenditures. Reinvestment rate: 16.8%. Owner Earnings have declined at 17.8% annually over the trailing five years using log-linear regression.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:2.13
Market Cap:$12.83M

Valuation Multiples (3)

P/B Ratio:0.20x
P/S Ratio:0.09x
Peg Ratio:-999.00x

Enterprise Metrics (2)

Enterprise Value:$50.10M
Pfcf Ratio:12.18x

Price Action & Momentum (3)

Momentum Percentile:18 / 100
% of 52-Week High:42.9%
B. Profitability Assessment

Return Metrics (5)

ROA:-9.3%
Reinvestment Rate:16.8%
Fundamental Growth Rate (g):-0.9%

Margin Analysis (3)

Operating Margin Ttm:-5.3%
Net Margin Ttm:-10.1%
Ebitda Margin:-2.0%

TTM Performance (3)

Gross Margin Ttm:7.6%
Operating Margin Ttm:-5.3%
Net Margin Ttm:-10.1%

Yield Metrics (3)

Earnings Yield:-$117.65
Owner Earnings Yield:$10.61
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends

Earnings Surprise (SUE) (3)

EPS Surprise vs Expected:-160.9%
Latest Earnings Filed:2026-05-19

Revenue Growth (Linear) (1)

Revenue Growth Rate (Linear):-12.0%

Earnings Growth (Linear) (1)

Net Income Growth Rate (Linear):-30.6%

Cash Flow Growth (Linear) (2)

Free Cash Flow Growth Rate (Linear):-5.2%
Operating Cash Flow Growth Rate (Linear):-40.2%

Operating Growth (Linear) (1)

Operating Income Growth Rate (Linear):-50.0%
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:1.64x
Quick Ratio:0.87x
Cash Ratio:0.24x

Leverage Analysis (3)

Debt To Equity Ttm:1.48x
Debt-to-Equity Ratio:1.48x
Debt To Ebitda:-999.00x

Coverage Ratios (1)

Times Interest Earned:-999.00

Capital Structure (4)

Working Capital:24,870,000.00
Cash And Cash Equivalents:9,196,000.00
Long Term Debt:$44.10M
Net Debt:$37.27M
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

Revenue TTM: $141.87M
Linear Growth: -12.0%
📊 Click to view full NAII Revenue analysis & methodology →
Cost Of Revenue Ttm:$131.07M

Profitability Breakdown (2)

Gross profit TTM: $10.81M
Linear Growth: -30.5%
📊 Click to view full NAII Gross Profit analysis & methodology →
Operating income TTM: -$7.52M
Linear Growth: -50.0%
📊 Click to view full NAII Operating Income analysis & methodology →

Bottom Line Performance (3)

Net income TTM: -$14.37M
Linear Growth: -30.6%
📊 Click to view full NAII Net Income analysis & methodology →
Income Before Tax:-$9.59M
Ebitda Ttm:-2,835,000.00

Operating Expenses (5)

Operating Expenses:0.00
R And D Expense:1,800,000.00
Sga Expense:16,774,000.00
Income Tax Expense:$5.10M
Interest Expense:-933,000.00

Expense Ratios (3)

R And D To Revenue Percentage:5.1%
Sga To Revenue Percentage:47.3%
Ebitda Margin:-2.0%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$154.88M
Current Assets:$64.00M
Ppe Net:50,813,000.00
Goodwill:0.00
Intangible Assets:$0.00

Liability Structure (4)

Total Liabilities:91,770,000.00
Current Liabilities:39,125,000.00
Long Term Debt:$44.10M
Short Term Debt:$2.36M

Equity & Capital (3)

Equity:$63.11M
Retained Earnings:$52.24M
Common Stock:20,000,000.00

Working Capital Items (3)

Accounts Receivable:20,588,000.00
Inventory:29,934,000.00
Accounts Payable:18,156,000.00

Special Items (2)

Contract Liabilities:1,323,000.00
Stock Based Compensation:140,000.00
C. Cash Flow Analysis

Operating Activities (2)

Operating cash flow TTM: $5.35M
Linear Growth: -40.2%
Free cash flow TTM: $1.01M
Linear Growth: -5.2%
📊 Click to view full NAII Free Cash Flow analysis & methodology →

Investment Activities (2)

Investing Cash Flow:-$1.03M
Capital Expenditures Ttm:4,343,000.00

Financing Activities (3)

Financing Cash Flow:$472.00K
Dividends Paid Ttm:0.00
Stock Repurchase:5,000.00

Capital Transactions (3)

Common Stock Issuance:0.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$74.00K

Non-Cash Items (1)

Depreciation Amortization Ttm:4,686,000.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-2.40
Eps diluted TTM: -$2.40
Linear Growth: -26.9%
📊 Click to view full NAII EPS analysis & methodology →
Earnings Per Share Ttm:-$2.39

Revenue & Cash Per Share (3)

Sales Per Share Ttm:23.55
Operating Cash Flow Per Share:$0.98
Fcf Per Share Ttm:0.17

Book Value & Capital (2)

Book Value Per Share:$10.47
Cash Per Share:1.53

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:0.92x
Working Capital Turnover Ttm:5.70x

Receivables Management (2)

Receivables Turnover Ttm:6.89x
Days Sales Outstanding Ttm:52.97

Inventory Management (2)

Inventory Turnover Ttm:4.38x
Days Inventory Outstanding Ttm:83.36

Payables & Cash Cycle (2)

Days Payable Outstanding:50.56
Cash Conversion Cycle:85.77
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:60.00
Quality Score:40.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Owner Earnings Analysis (3)

Owner earnings TTM: $1.30M
Linear Growth: -17.8%
📊 Click to view full NAII Owner Earnings analysis & methodology →
Owner Earnings Per Share:$0.22
Owner Earnings Yield:$10.61

Growth Assessment (1)

Owner Earnings Growth Rate:-$17.80

Damodaran Growth Analysis (2)

Reinvestment Rate:16.8%
Fundamental Growth Rate (g):-0.9%

Intrinsic Value Models (1)

Return Scenarios (2)

Investment Assessment (1)

Buffett Assessment:Overvalued
B. Log-Linear Regression Growth Analysis

Growth Rates (Log-Linear Regression) (3)

Revenue Growth Rate (Linear):-12.0%
Net Income Growth Rate (Linear):-30.6%
Operating Income Growth Rate (Linear):-50.0%

Cash Flow Growth Rates (2)

Free Cash Flow Growth Rate (Linear):-5.2%
Operating Cash Flow Growth Rate (Linear):-40.2%

Other Growth Rates (3)

Gross Profit Growth Rate (Linear):-30.5%
Book Value Growth Rate (Linear):-1.9%
Owner Earnings Growth Rate:-$17.80
C. Company Profile & Context

Corporate Information (6)

Symbol:NAII
Company Name:NATURAL ALTERNATIVES INTERNATIONAL INC
Sector:Healthcare
Industry:Pharmaceuticals
Exchange:NASDAQ
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:low
Volume Category:N/A

Share Structure (3)

Shares Outstanding:6.03M
Shares Outstanding Basic:6.03M
Shares Outstanding Diluted:6.03M

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-09-01 13:40:02 UTC
Data Timestamp:2026-08-21T09:18:48.234642
Scroll to Top